A detailed history of Commonwealth Equity Services, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 20,000 shares of CNTB stock, worth $19,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 20,000 -0.0%
Holding current value
$19,000
Previous $30,000 3.33%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$1.01 - $1.74 $20,200 - $34,800
20,000 New
20,000 $35,000

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $52.3M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.